IJMS | Free Full-Text | Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease
Subtyping of circulating exosome-bound amyloid β reflects brain plaque deposition | Nature Communications
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease - eBioMedicine
Frontiers | Amyloid-β Peptide Impact on Synaptic Function and Neuroepigenetic Gene Control Reveal New Therapeutic Strategies for Alzheimer's Disease
Amyloid β toxic conformer has dynamic localization in the human inferior parietal cortex in absence of amyloid plaques | Scientific Reports
Fc effector of anti-Aβ antibody induces synapse loss and cognitive deficits in Alzheimer's disease-like mouse model | Signal Transduction and Targeted Therapy
Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer's Disease Therapeutics
Boxplots of raw plasma biomarker levels for amyloid PET... | Download Scientific Diagram
Pyroglutamate Aβ cascade as drug target in Alzheimer's disease | Molecular Psychiatry
IJMS | Free Full-Text | Amyloid Beta in Aging and Alzheimer’s Disease
New Alzheimer's Biomarkers may Support Early Diagnosis
β-Secretase1 biological markers for Alzheimer's disease: state-of-art of validation and qualification | Alzheimer's Research & Therapy | Full Text
Biomedicines | Free Full-Text | Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers
Synergistic Association between Plasma Aβ1–42 and p-tau in Alzheimer's Disease but Not in Parkinson's Disease or Frontotemporal Dementia | ACS Chemical Neuroscience
Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review - ScienceDirect
Association of naturally occurring antibodies to β-amyloid with cognitive decline and cerebral amyloidosis in Alzheimer's disease | Science Advances
Amyloid-β (Aβ) marker expression and Aβ aggregation in the... | Download Scientific Diagram
Clinical significance of fluid biomarkers in Alzheimer's Disease | SpringerLink
Biofluid Biomarkers of Alzheimer's Disease: Progress, Problems, and Perspectives | SpringerLink
Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline | Alzheimer's Research & Therapy | Full Text
Nanoscale structure of amyloid-β plaques in Alzheimer's disease | Scientific Reports
Amyloid‐β oligomers in cellular models of Alzheimer's disease - Fontana - 2020 - Journal of Neurochemistry - Wiley Online Library
JPM | Free Full-Text | Advantages and Pitfalls in Fluid Biomarkers for Diagnosis of Alzheimer's Disease
JPM | Free Full-Text | Biomarkers for Alzheimer's Disease Early Diagnosis
Amyloid-β (Aβ) marker expression and Aβ aggregation in the... | Download Scientific Diagram
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study - The Lancet Neurology
The complexity of Alzheimer's disease: an evolving puzzle | Physiological Reviews
Amyloid blood biomarker detects Alzheimer's disease | EMBO Molecular Medicine
Refining the amyloid β peptide and oligomer fingerprint ambiguities in Alzheimer's disease: Mass spectrometric molecular characterization in brain, cerebrospinal fluid, blood, and plasma - Michno - 2021 - Journal of Neurochemistry - Wiley Online Library
Frontiers | Bridging the Gap Between Fluid Biomarkers for Alzheimer's Disease, Model Systems, and Patients
Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer's Disease | PLOS ONE
Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease by the Plasma and Serum Amyloid-beta 42 Assay through Highly Sensitive Peptoid Nanosheet Sensor | ACS Applied Materials & Interfaces
